Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AMERICAN BIO MEDICA CORP (ABMC)
|
Add to portfolio |
|
|
|
| Price: |
$0.04
| | Metrics |
| OS: |
48.1
|
M
| |
|
|
| Market cap: |
$1.77
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
($0.01)
| |
-3.86
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.9 | 2.2 | 4.1 | 3.7 | 3.9 | 4.9 | 5.6 | 6.3 |
| Revenue growth | -58.8% | -46.5% | 13.5% | -5.6% | -21.2% | -12.4% | -11.2% | -13.3% |
| Cost of goods sold | 1.1 | 1.7 | 2.9 | 2.5 | 2.6 | 2.9 | 3.1 | 3.5 |
| Gross profit | -0.2 | 0.5 | 1.2 | 1.2 | 1.3 | 2.0 | 2.5 | 2.9 |
| Gross margin | -21.1% | 24.7% | 29.9% | 32.4% | 33.3% | 40.6% | 44.4% | 45.2% |
| Sales and marketing | 0.1 | 0.3 | 0.5 | 0.5 | 0.5 | 0.7 | 1.1 | 1.2 |
| Research and development | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
| General and administrative | 0.9 | 1.3 | 1.3 | 1.2 | 1.4 | 1.5 | 1.5 | 1.6 |
| EBIT | -1.2 | -1.2 | -0.6 | -0.6 | -0.8 | -0.3 | -0.3 | 0.0 |
| EBIT margin | -136.0% | -53.2% | -15.0% | -16.2% | -19.7% | -6.3% | -4.6% | -0.2% |
| Pre-tax income | -1.4 | -0.5 | -0.8 | -0.7 | -1.0 | -0.5 | -0.3 | -0.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.7% | | 0.0% | | |
| Net income | -1.4 | -0.5 | -0.8 | -0.7 | -1.0 | -0.5 | -0.3 | -0.3 |
| Net margin | -154.4% | -20.9% | -19.2% | -18.6% | -26.5% | -11.1% | -6.2% | -5.3% |
| |
| Diluted EPS | ($0.03) | ($0.01) | ($0.02) | ($0.02) | ($0.03) | ($0.02) | ($0.01) | ($0.01) |
| Shares outstanding (diluted) | 48.0 | 42.8 | 35.6 | 32.5 | 30.1 | 29.2 | 27.5 | 25.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|